Design and optimization of peptide nanoparticles.

Area of Science:

• Biophysics
• Synthetic Biology
• Materials Science

Background:

• Proteins can self-assemble into symmetric supramolecular structures like viruses and vaults.
• Peptide/protein-based nanoparticles are increasingly used in synthetic biology for biomedical applications, including drug delivery and vaccines.
• The studied self-assembling peptide nanoparticles (SAPNs) are constructed from single peptide chains with two helical coiled-coil segments.

Purpose of the Study:

• To investigate the impact of peptide chain length and linker-region mutations on SAPN self-assembly.
• To develop smaller, efficient peptide nanoparticles for biomedical use.

Main Methods:

• In vitro biochemical and biophysical assays were employed.
• In silico molecular dynamics simulations were used to study various peptide constructs.
• Computational modeling was combined with experimental verification.

Main Results:

• Sixty peptide chains self-assemble into spherical nanoparticles with icosahedral symmetry.
• The minimal peptide chain length for self-assembly was reduced to 36 amino acids.
• One peptide construct demonstrated significant promise as a mini-nanoparticle model in silico.

Conclusions:

• In silico modeling and in vitro verification successfully yielded peptide designs for self-assembling nanoparticles.
• Reduced peptide chain length (36 amino acids) lowers production costs.
• The resulting nanoparticles (<20 nm) exhibit reduced immunogenicity, enhancing their potential for safe drug delivery systems.